March 21th, the Xinhua News Agency published an article named Research
found: Oxytocin is expected to be a cure of autism. This article reported
the results of one of Keith Kendrick’s empirical articles from the journal Neuroendocrinology. The
Xinhua News Agency’s article has been reprinted by more than twenty newspapers,
websites and social media both by domestic and international media. Here is the
original post from the Xinhua News Agency:
Scientists found that, the so-called “love
hormone”, oxytocin, can actually improve the symptoms of autism. Researchers in
UESTC found out that oxytocin accelerate the preference of attention towards
positive facial expression among individuals with high autism trait. This
result was published lately on an international academic journal: Neuroendocrinology.
Oxytocin is a neuropeptide hormone which is
produced and released by hypothalamus; it exists universally in human beings
and animals and is essential when giving birth or establish mother-child attachment.
Previous researches proved that oxytocin influence our brains in many ways: it’s
important in socializing and intimate relationships; it also increases the
facial identification ability and decrease the behavior which is antisocial or anxiety
oriented.
World famous neural scientist, Professor
Kendrick, in 1980s, discovered oxytocin’s effect on the pro-social behaviors of
sheep, such as nursing newborns and building mother-child attachment. This
study had drawn the starting point of the oxytocin pro-social research in the
scientific world. Nowadays, Professor Kendrick shifted his interest to the probabilities
of oxytocin becoming the treatment of psychological disorders.
In his experiment, Professor Kendrick
randomly assigned 60 university students into two groups, one group was given
intranasal administration of oxytocin, and the other group was given placebo
(normal saline). When the oxytocin was fully absorbed, 45 minutes after
administration, two groups of students were asked to complete a task that tests
their preferences of faces. The facial expressions of the stimuli were categorized
as: neutral (flat), positive (happy) and negative (angry, sad and fear). Results
showed that subjects administrated oxytocin tended to prefer neutral and
positive facial expressions, and that was particularly obvious among students
high on autism trait.
“This study
indicates that oxytocin significantly improved the high- autism trait subjects’
preference while observing positive faces.” Professor Kendrick stated, “Which carries
potentially medical value towards treatment of autism spectrum disorder, and
hopefully could be introduced to clinical experiments and applications”.